Clobazam Suspension
Product Images NDC 31722-641

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 31722-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clobazamosstructure (Clobazamosstructure)

Chemical structure of Clobazam, showing the molecular arrangement including a chlorine-substituted aromatic ring, a diazepine ring, and attached functional groups consistent with the Clobazam molecule.*

FDA Label Image

Clobazamosfigure1 (Clobazamosfigure1)

A bar graph showing percent reduction in weekly drop seizure rate for four groups: Placebo, Low, Medium, and High doses. The reductions increase from Placebo (-12.1%) to High (-68.3%), with statistical significance indicated for Low, Medium, and High dose groups compared to Placebo. Sample sizes for each group range from 49 to 58.*

FDA Label Image

Clobazamosfigure2 (Clobazamosfigure2)

A bar chart displaying the proportion of patients (%) against categories of reduction in weekly drop seizure frequency from baseline (%). It compares Placebo, Clobazam Low, Clobazam Medium, and Clobazam High dose groups across seizure frequency reduction ranges from 'Worse' to '80 to 100%'. The chart shows varying efficacy percentages among dosage groups.*

FDA Label Image

Clobazamoscamberlogo (Clobazamoscamberlogo)

FDA Label Image

Clobazamosfigurea (Clobazamosfigurea)

Clobazam Oral Suspension 2.5 mg/mL in a 120 mL bottle, shown with a white bottle adapter and two oral syringes. The label and box display the product name, strength, dosage form, and indicate oral administration only. Manufactured by Camber Pharmaceuticals, Inc.*

FDA Label Image

Clobazamosfigureb (Clobazamosfigureb)

Clobazam oral suspension 2.5 mg/mL in a 120 mL brown bottle with a white child-resistant cap, labeled by Camber Pharmaceuticals, Inc. The label includes instructions to shake well before use and indicates the product is prescription only.*

FDA Label Image

Clobazamosfigurec (Clobazamosfigurec)

An instructional diagram showing a close-up of a person's hand removing or placing a white plastic cap or closure above a bottle neck, indicated by a downward black arrow. The illustration highlights the correct placement or sealing of the cap on the bottle.*

FDA Label Image

Clobazamosfigured (Clobazamosfigured)

Illustration of an oral syringe used for dosing medication, showing labeled parts including the tip, dosage indicators, barrel, plunger, and violet ring on the plunger. The image highlights key components relevant for measuring and administering Clobazam oral suspension accurately.*

FDA Label Image

Clobazamosfiguree (Clobazamosfiguree)

An instructional illustration showing a hand inserting a dosing syringe into the neck of a bottle, demonstrating the proper method to draw liquid medication from the bottle using the syringe.*

FDA Label Image

Clobazamosfiguref (Clobazamosfiguref)

Black and white instructional image showing a person holding a syringe and a bottle, demonstrating liquid measurement or withdrawal from the bottle into the syringe. An arrow points downward, indicating the direction of liquid flow or syringe movement.*

FDA Label Image

Clobazamosfigureg (Clobazamosfigureg)

An instructional diagram for measuring Clobazam oral suspension. The image shows a dosing syringe with liquid filled up to the level marked by a violet ring, accompanied by an arrow pointing to the ring with the label 'Measure to violet ring.' This indicates the correct filling level for administration.*

FDA Label Image

Clobazamosfigureh (Clobazamosfigureh)

Black and white photo of a young child receiving oral medication from a syringe, demonstrating the administration of a liquid suspension drug.*

FDA Label Image

Clobazamosfigurei (Clobazamosfigurei)

Clobazam oral suspension bottle with 2.5 mg/mL strength from Camber Pharmaceuticals, Inc. The image shows a close-up of the bottle's white child-resistant cap being gripped by two fingers. The label displays the product name, strength, and NDC 31722-641-12.*

FDA Label Image

Clobazamoslabel (Clobazamoslabel)

Label for Clobazam Oral Suspension 2.5 mg/mL, an oral liquid medication in a 120 mL container by Camber Pharmaceuticals, Inc. The label includes dosage strength, usage instructions, storage conditions, and contact information, with emphasis on dispensing the medication guide and proper container handling.*

FDA Label Image

Clobazamoscarton (Clobazamoscarton)

Clobazam Oral Suspension 2.5 mg/mL by Camber Pharmaceuticals, Inc. The 120 mL bottle label indicates this prescription oral suspension is for oral administration only. The label includes dosage strength, pharmacist instructions, storage conditions, and manufacturer information, including production by Hetero Labs Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.